ArcticZymes Technologies ASA (OSL: AZT)
Norway
· Delayed Price · Currency is NOK
13.10
-0.08 (-0.61%)
Nov 21, 2024, 4:27 PM CET
AZT Revenue
ArcticZymes Technologies ASA had revenue of 24.11M NOK in the quarter ending September 30, 2024, a decrease of -22.60%. This brings the company's revenue in the last twelve months to 110.76M, down -6.92% year-over-year. In the year 2023, ArcticZymes Technologies ASA had annual revenue of 119.65M, down -13.09%.
Revenue (ttm)
110.76M
Revenue Growth
-6.92%
P/S Ratio
6.33
Revenue / Employee
2.09M
Employees
61
Market Cap
673.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 119.65M | -18.02M | -13.09% |
Dec 31, 2022 | 137.67M | 6.62M | 5.05% |
Dec 31, 2021 | 131.05M | 33.23M | 33.96% |
Dec 31, 2020 | 97.82M | 48.65M | 98.92% |
Dec 31, 2019 | 49.18M | -23.64M | -32.46% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Carasent ASA | 264.80M |
Photocure ASA | 526.25M |
Nykode Therapeutics AS | 69.44M |
Gentian Diagnostics ASA | 154.12M |
Hofseth BioCare ASA | 248.08M |
Navamedic ASA | 525.55M |